Arshia Sadreddin

Arshia Sadreddin practices at Sutter Pacific Medical Foundation in San Francisco, California.

Arshia Sadreddin's NPI, 1033308903, was assigned on October 17, 2007. Arshia Sadreddin graduated from Ross University School of Medicine in 2004. Arshia Sadreddin holds California license A121600.

Arshia Sadreddin's primary practice is Sutter Pacific Medical Foundation, at 1100 Van Ness Ave, San Francisco, CA 94109 in San Francisco County. The practice phone is (916) 732-4380.

Arshia Sadreddin's primary practice is Sutter Pacific Medical Foundation in San Francisco, California. Arshia Sadreddin is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Arshia Sadreddin to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Arshia Sadreddin practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Arshia Sadreddin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Arshia Sadreddin is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Arshia Sadreddin's licenses on file in 2 states: California and Arizona.

Dmand AI lists epilepsy, essential tremor and parkinson's disease among the conditions Arshia Sadreddin treats.

CMS data shows 9,858 Medicare services from Arshia Sadreddin across 10 procedure codes in 2024, for 227 Medicare patients. Medicare paid $133,182 for them.

CMS counts 227 Medicare patients who saw Arshia Sadreddin in 2024. The largest group is 75 to 84, with 110 patients. 70% of them have high cholesterol, and 69% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Arshia Sadreddin's median patient age at 73, with 42% women.

In 2024, Arshia Sadreddin wrote 713 Medicare Part D claims for 173 patients. 81% of them were for generic drugs. CMS names the drug for 614 of them, across 15 drugs with 11 or more claims each, at $209,771 in total drug cost. In 2023, CMS named 618 claims across 10 drugs.

Arshia Sadreddin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Arshia Sadreddin as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Arshia Sadreddin, published from 2012 to 2019. 2013 was the busiest year, with 2. The most frequent topics are Parkinson Disease, Fingers and Tremor. Arshia Sadreddin has published most often in Int J Neurosci. Arshia Sadreddin's most frequent co-authors are Anthony J. Santiago, MD, Sara Sherali Dhanani, MD and John P. Karis, MD.

CMS Open Payments shows 440 general payments to Arshia Sadreddin from 34 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Neurocrine BioSciences, Inc. paid the most, $62,555.

Arshia Sadreddin graduated from Ross University School of Medicine in 2004. Arshia Sadreddin is a member of AAN.

Arshia Sadreddin is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.